ConductScience.org, home

Paper6968614

Hydrallazine in hypertension: is there a safe dose?

Bing RF and 3 others. Br Med J, 1980. Cited by 28 papers, by iCite.

Cite this record

ConductScience Library. Hydrallazine in hypertension: is there a safe dose? Papers, record 6968614. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6968614

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hydrallazine in hypertension: is there a safe dose?
PubMed
Journal
Br Med J
PubMed
Year
1980
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
28
iCite
Relative citation ratio, by iCite
1.66
iCite
Revised in PubMed
2019-05-01
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bing RFR F
2Russell GIG I
3Thurston HH
4Swales JDJ D

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HydralazineMajor topic
HypertensionMajor topic
Adult
Antibodies
Antibodies, Antinuclear
DNA
Female
Humans
Lupus Erythematosus, Systemic
Male
Middle Aged

Source PubMed

Download CSV of topics

References3

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14912962Relationship of acetyl transferase activity to antinuclear antibodies and toxic symptoms in hypertensive patients treated with hydralazine.J Lab Clin Med1970https://conductscience.org/library/papers/4912962PubMed
24403571Simplified method for determining acetylator phenotype.Br Med J1972https://conductscience.org/library/papers/4403571PubMed
34581906Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis.Am J Med1973https://conductscience.org/library/papers/4581906PubMed

Download CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.

PMIDTitleJournalYearIn PapersSource
20544243Acrylamine-induced autoimmune phenomena.Clin Rheumatol2010https://conductscience.org/library/papers/20544243PubMed
7066169The addition of prazosin to standard triple therapy in the treatment of severe hypertension.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7066169PubMed
7011656Acetylator phenotype and lupus erythematosus.Clin Pharmacokinet1981https://conductscience.org/library/papers/7011656PubMed
6984902Endralazine in patients with severe hypertension and renal insufficiency.Postgrad Med J1982https://conductscience.org/library/papers/6984902PubMed
6861845Endralazine, a new peripheral vasodilator. Evaluation of safety and efficacy over a 3 year period.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6861845PubMed
6814636Transient monoclonal gammopathy in hydralazine-induced lupus erythematosus.Br Med J (Clin Res Ed)1982https://conductscience.org/library/papers/6814636PubMed
6786464Hydralazine-induced necrotising vasculitis.Br Med J (Clin Res Ed)1981https://conductscience.org/library/papers/6786464PubMed
6714290Should the acetylator phenotype be determined when prescribing hydralazine for hypertension?Eur J Clin Pharmacol1984https://conductscience.org/library/papers/6714290PubMed
6432120The lupus syndrome induced by hydralazine: a common complication with low dose treatment.Br Med J (Clin Res Ed)1984https://conductscience.org/library/papers/6432120PubMed
6419809"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.Br Med J (Clin Res Ed)1984https://conductscience.org/library/papers/6419809PubMed
6148121The third drug in hypertension.Br Med J (Clin Res Ed)1984https://conductscience.org/library/papers/6148121PubMed
2874821Felodipine vs hydralazine: a controlled trial as third line therapy in hypertension. Cooperative Study Group.Br J Clin Pharmacol1986https://conductscience.org/library/papers/2874821PubMed
2168822Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus.Clin Exp Immunol1990https://conductscience.org/library/papers/2168822PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6968614

GET https://conductscience.org/api/papers/v1/6968614/authors